Hans Peter Mulder

At Idris Oncology, we are developing novel tools to aid clinicians in the diagnosis, treatment selection and monitoring of life-threatening diseases. Precision medicine has transformed cancer care. Therapies are now selected to specifically target molecular markers present within a patient's tumor. However, if you cannot see the target, how do you know what to aim for? Standard biopsies can give doctors this information, yet for too long they have been unreliable and often dangerous. Idris Oncology is committed to providing clinicians with the best tools to sample a patient's tumor cells and tumor cell products. Only with the best information can patients receive the best care. Find out more about our technology, visit www.idrisoncology.com